{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:47:55Z","timestamp":1774648075411,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24112"],"award-info":[{"award-number":["24112"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K11288"],"award-info":[{"award-number":["17K11288"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26462531"],"award-info":[{"award-number":["26462531"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vaccine.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T07:37:22Z","timestamp":1621237042000},"page":"3498-3508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model"],"prefix":"10.1016","volume":"39","author":[{"given":"Michiko","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Miyanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Teshigawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.05.010_b0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0031-1283287","article-title":"Adenovirus","volume":"32","author":"Lynch","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2021.05.010_b0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/JCM.05629-11","article-title":"Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources","volume":"50","author":"Buckwalter","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0015","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.45.19707-en","article-title":"Increasing case numbers of adenovirus conjunctivitis in Germany, 2010","volume":"15","author":"Adlhoch","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2021.05.010_b0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.survophthal.2015.04.001","article-title":"Adenoviral keratoconjunctivitis","volume":"60","author":"Jhanji","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0025","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.122.3181.1190.b","article-title":"new type of APC virus from epidemic keratoconjunctivitis","volume":"122","author":"Jawetz","year":"1955","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2021.05.010_b0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcv.2014.10.015","article-title":"Human adenovirus type 8: the major agent of epidemic keratoconjunctivitis (EKC)","volume":"61","author":"Adhikary","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","article-title":"Epidemiology of epidemic keratoconjunctivitis","volume":"9","author":"Ford","year":"1987","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2021.05.010_b0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.virol.2015.08.018","article-title":"Recombination of the epsilon determinant and corneal tropism: Human adenovirus species D types 15, 29, 56, and 69","volume":"485","author":"Singh","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.05.010_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005635","article-title":"Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis","volume":"4","author":"Walsh","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.010_b0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7883\/yoken.JJID.2019.064","article-title":"Conjunctivitis due to the human adenovirus type 2 variant identified during epidemic keratoconjunctivitis surveillance in Japan","volume":"72","author":"Kaneko","year":"2019","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.05.010_b0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/s12879-019-4232-8","article-title":"An outbreak of epidemic keratoconjunctivitis caused by human adenovirus type 8 in primary school, southwest China","volume":"19","author":"Li","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.05.010_b0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.optm.2006.11.012","article-title":"The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room","volume":"78","author":"Sambursky","year":"2007","journal-title":"Optometry"},{"key":"10.1016\/j.vaccine.2021.05.010_b0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1017\/S0950268815003246","article-title":"Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953\u20132013","volume":"144","author":"Zhang","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.05.010_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2019.01.004","article-title":"Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses","volume":"112","author":"Gonzalez","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0075","unstructured":"Hogan MJ, Crawford JW. Epidemic Keratoconjunctivitis: (Superficial Punctate Keratitis, Keratitis Subepithelialis, Keratitis Maculosa, Keratitis Nummularis) With a Review of the Literature and a Report of 125 Cases. Am J Ophthalmol. 2018;190:xxix-xlii."},{"key":"10.1016\/j.vaccine.2021.05.010_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1076\/opep.6.1.29.1564","article-title":"Prevention and control of epidemic keratoconjunctivitis in a teaching eye institute","volume":"6","author":"Gottsch","year":"1999","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0085","doi-asserted-by":"crossref","unstructured":"Gordon YJ, Gordon RY, Romanowski E, Araullo-Cruz TP. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology. 1993;100:1835-9; discussion 9-40.","DOI":"10.1016\/S0161-6420(93)31389-8"},{"key":"10.1016\/j.vaccine.2021.05.010_b0090","first-page":"475","article-title":"Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment","volume":"108","author":"Meyer-Rusenberg","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.vaccine.2021.05.010_b0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","article-title":"Human adenovirus: Viral pathogen with increasing importance","volume":"4","author":"Ghebremedhin","year":"2014","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10.1016\/j.vaccine.2021.05.010_b0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/IDR.S162669","article-title":"Pathogenesis and management of adenoviral keratoconjunctivitis","volume":"11","author":"Chigbu","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2021.05.010_b0105","first-page":"917","article-title":"The clinical features of viral keratitis and a concept of their pathogenesis","volume":"51","author":"Jones","year":"1958","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.vaccine.2021.05.010_b0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","article-title":"The effects of corticosteroids of adenoviral replication","volume":"114","author":"Romanowski","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","article-title":"The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study","volume":"109","author":"Hillenkamp","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2021.05.010_b0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2008-1046272","article-title":"Epidemic keratoconjunctivitis: treatment results during an epidemic","volume":"197","author":"Hutter","year":"1990","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.vaccine.2021.05.010_b0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00003226-199409000-00011","article-title":"Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes","volume":"13","author":"Trousdale","year":"1994","journal-title":"Cornea"},{"key":"10.1016\/j.vaccine.2021.05.010_b0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00003226-199305000-00006","article-title":"A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis","volume":"12","author":"Ward","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.vaccine.2021.05.010_b0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0002-9394(76)90017-9","article-title":"Use of vidarabine in epidemic keratoconjunctivitis due to adenovirus types 3, 7, 8, and 19","volume":"82","author":"Waring","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0140","first-page":"315","article-title":"Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods","volume":"8","author":"Huang","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2008-1046070","article-title":"Local prevention with interferon of \u201cepidemic\u201d conjunctivitis caused by a currently unidentifiable virus","volume":"199","author":"Rossa","year":"1991","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.vaccine.2021.05.010_b0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.10-5944","article-title":"Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis","volume":"52","author":"Clement","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2021.05.010_b0155","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/ICO.0b013e3181c33034","article-title":"Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis","volume":"29","author":"Levinger","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.vaccine.2021.05.010_b0165","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","article-title":"Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species","volume":"80","author":"Jogler","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0170","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/archopht.1992.01080200147043","article-title":"An experimental animal model of adenovirus-induced ocular disease","volume":"110","author":"Tsai","year":"1992","journal-title":"The cotton rat Arch Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1167\/iovs.06-1036","article-title":"Adenovirus type 37 keratitis in the C57BL\/6J mouse","volume":"48","author":"Chintakuntlawar","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2021.05.010_b0180","first-page":"574","article-title":"An ocular model of adenovirus type 5 infection in the NZ rabbit","volume":"33","author":"Gordon","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2021.05.010_b0185","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/BF00292359","article-title":"Orthotopic corneal transplantation in the mouse\u2013a new surgical technique with minimal endothelial cell loss","volume":"234","author":"Zhang","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00417-004-0952-5","article-title":"Low-dose anesthesia for corneal transplantation in mice","volume":"243","author":"Zhang","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0195","first-page":"138","article-title":"IgG and IgA antibody in tears of rabbits immunized by topical application of ovalbumin","volume":"30","author":"Hall","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2021.05.010_b0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-1119(02)00410-9","article-title":"Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes","volume":"285","author":"Mizuguchi","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2021.05.010_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030302","article-title":"Immunogenic comparison of chimeric adenovirus 5\/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters","volume":"7","author":"Shoji","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.010_b0210","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/sj.gt.3302590","article-title":"Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV","volume":"12","author":"Xin","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2021.05.010_b0215","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1016\/j.vaccine.2007.01.117","article-title":"Chimeric adenovirus 5\/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV","volume":"25","author":"Xin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.010_b0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.gt.3302232","article-title":"T-cell response to adenovirus hexon and DNA-binding protein in mice","volume":"11","author":"McKelvey","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2021.05.010_b0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/gt.2009.122","article-title":"Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys","volume":"17","author":"Wang","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2021.05.010_b0230","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1189\/jlb.1A0813-451RR","article-title":"The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses","volume":"96","author":"Small","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0235","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.4049\/jimmunol.125.6.2665","article-title":"IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement","volume":"125","author":"Sarmiento","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0240","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jir.2009.0006","article-title":"Chemokine CXCL1\/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis","volume":"29","author":"Chintakuntlawar","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2021.05.010_b0245","first-page":"33","article-title":"An ocular model of Adenovirus type 5 infection in the rabbit","volume":"259","author":"De Hauwere","year":"1995","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0250","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2021.05.010_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169532","article-title":"Cell-surface integrins and CAR are both essential for adenovirus type 5 transduction of canine cells of lymphocytic origin","volume":"12","author":"Agarwal","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.010_b0260","doi-asserted-by":"crossref","first-page":"11284","DOI":"10.1128\/JVI.75.23.11284-11291.2001","article-title":"Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions","volume":"75","author":"Einfeld","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0265","first-page":"93","article-title":"Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages\/neutrophils: protective and deleterious effects","volume":"22","author":"Grivennikov","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2021.05.010_b0270","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4049\/jimmunol.173.2.721","article-title":"Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells","volume":"173","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.exer.2016.05.016","article-title":"Resident corneal c-fms(+) macrophages and dendritic cells mediate early cellular infiltration in adenovirus keratitis","volume":"147","author":"Ramke","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.vaccine.2021.05.010_b0280","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/icb.2016.73","article-title":"Role of MyD88 in adenovirus keratitis","volume":"95","author":"Zhou","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2021.05.010_b0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12985-017-0822-5","article-title":"Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies","volume":"14","author":"Pacesa","year":"2017","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2021.05.010_b0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mt.2012.248","article-title":"Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus","volume":"21","author":"Zhou","year":"2013","journal-title":"Mol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:56:32Z","timestamp":1759402592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21005612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":58,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0264410X21005612"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}